Considerations of Sex and Gender in FDA Tobacco Regulation
Danielle R. Davis, Suchitra Krishnan‐Sarin, Carolyn M. Mazure
Abstract
This Viewpoint discusses how sex and gender subpopulations may be differentially affected by tobacco products and suggests that the FDA formulate regulations in clinically meaningful ways.
Topics & Concepts
MedicineTobacco useEnvironmental healthPopulationSex and Gender in HealthcareGlobal Public Health Policies and EpidemiologySmoking Behavior and Cessation